Human amnion epithelial cells expressing HLA-G as novel cell-based treatment for liver disease

Davis, 1910, Skin transplantation with a review of 550 cases at the John Hopkins Hospital, John Hopkins Med. J., 15, 307 Trelford-Sauder, 1978, Use of allograft amniotic membrane for control of intra-abdominal adhesions, J. Med., 9, 273 Silverton, 1979, The use of amniotic membrane in acute massive full-thickness loss of the abdominal wall from clostridial myonecrosis, Ann. Plast. Surg., 3, 558, 10.1097/00000637-197912000-00012 Trelford, 1979, The amnion in surgery, past and present, Am. J. Obstet. Gynecol., 134, 833, 10.1016/0002-9378(79)90957-8 Young, 1991, The use of an amniotic membrane graft to prevent postoperative adhesions, Fertil. Steril., 55, 624, 10.1016/S0015-0282(16)54197-1 Gruss, 1978, Human amniotic membrane: a versatile wound dressing, Can. Med. Assoc. J., 118, 1237 Subrahmanyam, 1995, Amniotic membrane as a cover for microskin grafts, Br. J. Plast. Surg., 48, 477, 10.1016/0007-1226(95)90123-X Nisolle, 1992, Vaginoplasty using amniotic membranes in cases of vaginal agenesis or after vaginectomy, J. Gynecol. Surg., 8, 25, 10.1089/gyn.1992.8.25 Dhall, 1984, Amnion graft for treatment of congenital absence of the vagina, Br. J. Obstet. Gynaecol., 91, 279, 10.1111/j.1471-0528.1984.tb04768.x Brindeau, 1934, Creation d’un vagin artificiel a l’aide des membranes ovulaires d’un oeuf a terme, J. Gynecol. Obstet. Biol. Reprod., 13, 821 Arya, 2010, Role of amniotic membrane transplantation in ocular surface disorders, Nepal J. Ophthalmol., 2, 145, 10.3126/nepjoph.v2i2.3722 Murube, 2006, Early clinical use of amniotic membrane in medicine and ophthalmology, Ocul. Surf., 4, 114, 10.1016/S1542-0124(12)70037-X Gupta, 2015, Amnion and chorion membranes: potential stem cell reservoir with wide applications in periodontics, Int. J. Biomater., 2015, 10.1155/2015/274082 Magatti, 2009, Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes, Cell Transplant., 18, 899, 10.3727/096368909X471314 Parolini, 2007, Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells, Stem Cells Marongiu, 2010, Isolation of amniotic mesenchymal stem cells, Curr. Protoc. Stem Cell Biol., 10.1002/9780470151808.sc01e05s12 Miki, 2010, Isolation of amniotic epithelial stem cells, Curr. Protoc. Stem Cell Biol., 10.1002/9780470151808.sc01e03s12 Murphy, 2014, Isolation, cryopreservation and culture of human amnion epithelial cells for clinical applications, J. Vis. Exp., 10.3791/52085 Silini, 2015, The long path of human placenta, and its derivatives, in regenerative medicine, Front Bioeng. Biotechnol., 3, 162, 10.3389/fbioe.2015.00162 Yoshinaga, 2012, Two concepts on the immunological aspect of blastocyst implantation, J. Reprod. Dev., 58, 196, 10.1262/jrd.2011-027 Hsiao, 2012, Placental regulation of maternal-fetal interactions and brain development, Dev. Neurobiol., 72, 1317, 10.1002/dneu.22045 Fainardi, 2011, Emerging topics and new perspectives on HLA-G, Cell. Mol. Life Sci., 68, 433, 10.1007/s00018-010-0584-3 Gramignoli, 2016, Isolation of human amnion epithelial cells according to current good manufacturing procedures, Curr. Protoc. Stem Cell Biol., 10.1002/cpsc.2 Parolini, 2008, Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells, Stem Cells, 26, 300, 10.1634/stemcells.2007-0594 Takashima, 2008, Characterization of laminin isoforms in human amnion, Tissue Cell, 40, 75, 10.1016/j.tice.2007.09.001 Miki, 2005, Stem cell characteristics of amniotic epithelial cells, Stem Cells, 23, 1549, 10.1634/stemcells.2004-0357 Gramignoli, 2016, Use of amnion epithelial cells in metabolic liver disorders, Placenta: The Tree of Life, 10.1201/b19620-8 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Elwan, 1997, Evidence for synthesis and release of catecholamines by human amniotic epithelial cells, NeuroReport, 8, 3435, 10.1097/00001756-199711100-00004 Miki, 2009, Production of hepatocyte-like cells from human amnion, Methods Mol. Biol., 481, 155, 10.1007/978-1-59745-201-4_13 Miki, 2006, Amnion-derived pluripotent/multipotent stem cells, Stem Cell Rev., 2, 133, 10.1007/s12015-006-0020-0 Davila, 2004, Use and application of stem cells in toxicology, Toxicol. Sci., 79, 214, 10.1093/toxsci/kfh100 Wei, 2003, Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice, Cell Transplant., 12, 545, 10.3727/000000003108747000 Elwan, 1999, Evidence for the presence of dopamine D1 receptor mRNA and binding sites in monkey amniotic epithelial cells, Neurosci. Lett., 262, 9, 10.1016/S0304-3940(99)00016-6 Elwan, 2003, Characterization of the dopamine transporter gene expression and binding sites in cultured human amniotic epithelial cells, Neurosci. Lett., 342, 61, 10.1016/S0304-3940(03)00235-0 Sakuragawa, 1997, Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease, Neurosci. Lett., 232, 53, 10.1016/S0304-3940(97)00570-3 Ilancheran, 2007, Stem cells derived from human fetal membranes display multi-lineage differentiation potential, Biol. Reprod., 77, 577, 10.1095/biolreprod.106.055244 Tamagawa, 2004, Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro, Hum. Cell, 17, 125, 10.1111/j.1749-0774.2004.tb00028.x Chen, 2011, Prevalence of telomerase activity in human cancer, J. Formos. Med. Assoc., 110, 275, 10.1016/S0929-6646(11)60043-0 Hansel, 2014, Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions, Cell Transplant., 23, 27, 10.3727/096368912X662453 Miki, 2010, Isolation of amniotic epithelial cells, Curr. Protoc. Stem Cell Biol., 10.1002/9780470151808.sc01e03s12 Akle, 1981, Immunogenicity of human amniotic epithelial cells after transplantation into volunteers, Lancet, 2, 1003, 10.1016/S0140-6736(81)91212-5 Marongiu, 2015, Rat-derived amniotic epithelial cells differentiate into mature hepatocytes in vivo with no evidence of cell fusion, Stem Cells Dev., 24, 1429, 10.1089/scd.2014.0532 Skvorak, 2013, Placental stem cell correction of murine intermediate maple syrup urine disease, Hepatology, 57, 1017, 10.1002/hep.26150 Marongiu, 2011, Hepatic differentiation of amniotic epithelial cells, Hepatology, 53, 1719, 10.1002/hep.24255 Yeager, 1985, A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases, Am. J. Med. Genet., 22, 347, 10.1002/ajmg.1320220219 Banas, 2008, Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells, Hum. Immunol., 69, 321, 10.1016/j.humimm.2008.04.007 Deschaseaux, 2011, HLA-G in organ transplantation: towards clinical applications, Cell. Mol. Life Sci., 68, 397, 10.1007/s00018-010-0581-6 Hunt, 2005, HLA-G and immune tolerance in pregnancy, FASEB J., 19, 681, 10.1096/fj.04-2078rev Crisa, 1997, Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts, J. Exp. Med., 186, 289, 10.1084/jem.186.2.289 Le Discorde, 2003, Expression of HLA-G in human cornea, an immune-privileged tissue, Hum. Immunol., 64, 1039, 10.1016/j.humimm.2003.08.346 Ito, 2005, Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege, J. Invest Dermatol., 125, 1139, 10.1111/j.0022-202X.2005.23927.x Cirulli, 2006, The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G, Diabetes, 55, 1214, 10.2337/db05-0731 Tee, 2013, Immunogenicity and immunomodulatory properties of hepatocyte-like cells derived from human amniotic epithelial cells, Curr. Stem Cell Res. Ther., 8, 91, 10.2174/1574888X11308010011 Menier, 2010, Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule, Tissue Antigens, 75, 201, 10.1111/j.1399-0039.2009.01438.x Le Maux, 2008, Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells, Clin. Exp. Immunol., 152, 50, 10.1111/j.1365-2249.2008.03598.x Rajagopalan, 1999, A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells, J. Exp. Med., 189, 1093, 10.1084/jem.189.7.1093 Colonna, 1997, A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells, J. Exp. Med., 186, 1809, 10.1084/jem.186.11.1809 Colonna, 1998, Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules, J. Immunol., 160, 3096, 10.4049/jimmunol.160.7.3096 Shiroishi, 2003, Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G, Proc. Natl. Acad. Sci. USA, 100, 8856, 10.1073/pnas.1431057100 Selmani, 2009, HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells, Transplantation, 87, S62, 10.1097/TP.0b013e3181a2a4b3 Drukker, 2006, Immunogenicity of embryonic stem cells and their progeny, Methods Enzymol., 420, 391, 10.1016/S0076-6879(06)20019-3 Parolini, 2010, Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table, Stem Cells Dev., 19, 143, 10.1089/scd.2009.0404 Li, 2005, Immunosuppressive factors secreted by human amniotic epithelial cells, Invest. Ophthalmol. Vis. Sci., 46, 900, 10.1167/iovs.04-0495 Gramignoli, 2015, Clinical hepatocyte transplantation: practical limits and possible solutions, Eur. Surg. Res., 54, 162, 10.1159/000369552 Hansel, 2014, The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients, Curr. Protoc. Toxicol., 10.1002/0471140856.tx1412s62 Mitry, 2004, One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation, Transplantation, 77, 1614, 10.1097/01.TP.0000122224.98318.19 Gramignoli, 2013, New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants, Stem Cell Res., 11, 563, 10.1016/j.scr.2013.03.002 Puppi, 2012, Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London, Cell Transplant., 21, 1, 10.3727/096368911X566208 Strom, 2013, Translation of amnion stem cells to the clinic, Stem Cells Dev., 22, 96, 10.1089/scd.2013.0391 Puppi, 2009, Human hepatocyte transplantation overview, Methods Mol. Biol., 481, 1, 10.1007/978-1-59745-201-4_1 Groth, 1977, Correction of hyperbilirubinemia in the glucuronyltransferase-deficient rat by intraportal hepatocyte transplantation, Transplant. Proc., 9, 313 Skvorak, 2013, Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice, Mol. Genet. Metab., 109, 132, 10.1016/j.ymgme.2013.02.011